Abiraterone Acetate contains not less than 98.0% and not more than 102.0% of abiraterone acetate (C26H33NO2), calculated on the as-is basis.

共有 1 個藥物證書使用此成份

申請商
恒亞貿易股份有限公司 
適應症
抗腫瘤劑
含量
發證日期
2023-11-20